Stemirna Therapeutics Co.
Latest round
- Series A
Last raised
- Jul 2019
Total raised
- Undisclosed
Investors
- 5
About Stemirna Therapeutics Co.
, Ltd. is a biotechnology company that specializes in mRNA technology. Li Hangwen is the founder and current CEO of the company. It has partnerships with Baidu USA Research Institute, Oregon State University, and the University of Rochester. The company has 50,000 square meters of vaccine production base and 400 million doses of vaccine capacity as of 2023. The company focuses on developing and providing mRNA (mRNA stands for messenger RNA, it is the information carrier in the process of gene expression) drugs for different diseases, including cancer, contagion, and a genetic disorder. The company's platforms include an mRNA synthesis platform, an LPP (ipopolyplex) delivery platform, and GMP manufacturing (GMP-compliant facilities for manufacturing and quality control). The company has also developed a pipeline that spans different therapeutic areas, including immuno-oncology, infectious diseases, and iPSC, based on its mRNA synthesis platform and LPP delivery platform.
Who invested in Stemirna Therapeutics Co.
5 investors across 2 rounds
See all investors in Stemirna Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stemirna Therapeutics Co.
Who invested in Stemirna Therapeutics Co.?
Stemirna Therapeutics Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stemirna Therapeutics Co. raised?
Stemirna Therapeutics Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Stemirna Therapeutics Co. last raise money?
Stemirna Therapeutics Co.'s most recent round on record is a Series A, in Jul 2019.
What does Stemirna Therapeutics Co. do?
Stemirna Therapeutics Co. is a biotechnology company.
Where is Stemirna Therapeutics Co. headquartered?
Stemirna Therapeutics Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Stemirna Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Stemirna Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Stemirna Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.